Mi Propio Camino (MPC) for High Blood Pressure

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
High Blood Pressure+1 MoreMi Propio Camino (MPC) - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare two ways of teaching people with uncontrolled hypertension how to better manage their blood pressure medication.

Eligible Conditions
  • High Blood Pressure
  • Medication Adherence

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 7 Secondary · Reporting Duration: Collected for analysis at baseline, upon completion of intervention period and upon completion of outcome assessment period at 1-month and 6-month follow up.

6 months post-intervention
Medication Adherence (Objective)
Blood pressure will be collected for analysis at baseline, upon completion of intervention period and upon completion of outcome assessment period at 1-month and 6-month follow up.
Blood Pressure
Collected for analysis at baseline, upon completion of intervention period and upon completion of outcome assessment period at 1-month and 6-month follow up.
Activation of behavioral strategies
Medication Adherence (Subjective)
Medication-related Behavioral Skills
Medication-related beliefs (Specific)
Medication-related information
Reasons for Nonadherence

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Habilidades para Controlar la Presion (HCP; Skills for Blood Pressure Control)
1 of 2
Mi Propio Camino (MPC; My Own Way)
1 of 2

Active Control

Experimental Treatment

500 Total Participants · 2 Treatment Groups

Primary Treatment: Mi Propio Camino (MPC) · No Placebo Group · N/A

Mi Propio Camino (MPC; My Own Way)
Behavioral
Experimental Group · 1 Intervention: Mi Propio Camino (MPC) · Intervention Types: Behavioral
Habilidades para Controlar la Presion (HCP; Skills for Blood Pressure Control)
Behavioral
ActiveComparator Group · 1 Intervention: Habilidades para Controlar la Presion (HCP; Skills for Blood Pressure Control) · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: collected for analysis at baseline, upon completion of intervention period and upon completion of outcome assessment period at 1-month and 6-month follow up.

Who is running the clinical trial?

University of California, IrvineLead Sponsor
500 Previous Clinical Trials
1,880,952 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,588 Previous Clinical Trials
46,945,499 Total Patients Enrolled
John Billimek, PhDPrincipal InvestigatorUniversity of California, Irvine
1 Previous Clinical Trials
190 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: